September 2024
Diaceutics
Canaccord Genuity has been appointed as Nominated Adviser and Broker to Diaceutics plc
Canaccord Genuity’s Corporate Broking Team is pleased to announce it has been appointed as Nominated Adviser and Broker to Diaceutics plc.
Diaceutics is a leading technology and solutions providers to the global pharmaceutical and biotech industry. It has established a suite of data-driven solutions, powered by its proprietary database, to support the promotion, launch and commercialisation of precision medicines, and specifically, the diagnostic testing required to guide selection of such medicines. As such, Diaceutics helps pharma and biotech companies find the patients that will benefit the most from a precision medicine to help facilitate improved patient outcomes. The Group holds long-standing relationships with blue-chip pharma logos, including 17 of the 20 largest global pharmaceutical companies.